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Background: T2w-CMR is used widely to assess myocardial edema. Quantitative T1-mapping is also sensitive to
changes in free water content. We hypothesized that T1-mapping would have a higher diagnostic performance in
detecting acute edema than dark-blood and bright-blood T2w-CMR.
Methods: We investigated 21 controls (55 ± 13 years) and 21 patients (61 ± 10 years) with Takotsubo
cardiomyopathy or acute regional myocardial edema without infarction. CMR performed within 7 days included
cine, T1-mapping using ShMOLLI, dark-blood T2-STIR, bright-blood ACUT2E and LGE imaging. We analyzed wall
motion, myocardial T1 values and T2 signal intensity (SI) ratio relative to both skeletal muscle and
remote myocardium.
Results: All patients had acute cardiac symptoms, increased Troponin I (0.15-36.80 ug/L) and acute wall motion
abnormalities but no LGE. T1 was increased in patient segments with abnormal and normal wall motion compared
to controls (1113 ± 94 ms, 1029 ± 59 ms and 944 ± 17 ms, respectively; p< 0.001). T2 SI ratio using STIR and ACUT2E
was also increased in patient segments with abnormal and normal wall motion compared to controls (all p< 0.02).
Receiver operator characteristics analysis showed that T1-mapping had a significantly larger area-under-the-curve
(AUC= 0.94) compared to T2-weighted methods, whether the reference ROI was skeletal muscle or remote
myocardium (AUC= 0.58-0.89; p< 0.03). A T1 value of greater than 990 ms most optimally differentiated segments
affected by edema from normal segments at 1.5 T, with a sensitivity and specificity of 92 %.
Conclusions: Non-contrast T1-mapping using ShMOLLI is a novel method for objectively detecting myocardial
edema with a high diagnostic performance. T1-mapping may serve as a complementary technique to T2-weighted
imaging for assessing myocardial edema in ischemic and non-ischemic heart disease, such as quantifying
area-at-risk and diagnosing myocarditis.
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T2-weighted cardiovascular magnetic resonance (T2w-
CMR) is the standard imaging technique for detecting
acute myocardial edema in vivo [1]. It is used for differenti-
ation of acute from chronic MI [2], assessment of the area-
at-risk [3,4], myocarditis [5] and increasingly as a surrogate
end-point in clinical trials [6].
T2w-CMR techniques are sensitive to an increase in
myocardial water content and/or free water fractions [1,5-
7]. Conventional T2w images are acquired using the
short-tau inversion recovery (STIR) sequence at 1.5 T [8].
Limitations of this technique include signal drop-out,
bright signals adjacent to the subendocardium due to
slow-flow blood, image quality impairment in tachyar-
rhythmias, and long breath-holds [5,9]. Furthermore, there
is need for a “normal” reference region of interest (ROI),
either in remote myocardium, or in adjacent skeletal
muscle for conditions with diffuse edema. The use of an
ROI outside the myocardium typically requires the body
coil to minimize signal inhomogeneity [5], which gives a
lower SNR. In systemic conditions like viral myocarditis,
the reference skeletal muscle may also be inflamed, lead-
ing to false negative results [5]. The bright-blood T2-
weighted sequence ACUT2E [10] has been shown to be
superior to dark-blood STIR in assessing acute myocardial
infarction and area-at-risk [3], but has not been tested in
subjects with diffuse or patchy edema using reference
ROIs outside the myocardium.
T1-mapping may provide a quantitative means to detect
myocardial edema without the need for reference ROIs.
Each tissue type exhibits a characteristic range of normal
T1 relaxation times at a particular magnetic field strength
[11]. T1 and T2 times track closely together such that
myocardial edema, which prolongs T2, also prolongs T1
[1,6,12]. Increased T1 values have been shown in ischemic
tissue from dog hearts, which largely reflected increased
free water content [13], and in humans with acute myocar-
dial infarction [14,15]. However, the ability of T1-mapping
to detect edema in the absence of infarction has not been
systematically compared to T2w-CMR.
In this study, we compared T1-mapping using the novel
ShMOLLI sequence [16], dark-blood and bright-blood
T2w-CMR in the detection of acute myocardial edema.
Patients presenting with Takotsubo cardiomyopathy
(TCM) and regional edema in the absence of infarction
were included. This allowed testing of the performance of
each method in detecting both global and regional edema.
We hypothesized that quantitative T1-mapping would be
superior to T2-weighted methods that require reference
ROIs.
Methods
All subjects gave written informed consent and ethical ap-
proval was granted for all study procedures.Study population
Consecutive patients demonstrating CMR features of acute
Takotsubo cardiomyopathy or acute myocardial edema
without infarction were prospectively enrolled. The diag-
nosis of Takotsubo cardiomyopathy was based on the pro-
posed Mayo Clinic criteria [17]: (1) an acute cardiac event
presenting with chest pain and/or dyspnea; (2) transient
systolic dysfunction with marked LV contraction abnor-
mality (akinesis or dyskinesia of the LV apical and/or mid-
ventricular or basal segments) extending beyond a single
coronary perfusion bed; (3) absence of significant (>50 %)
obstructive coronary artery disease or angiographic evi-
dence of acute plaque rupture; (4) new ECG abnormalities
(either ST elevation or T wave inversion) or elevation in
cardiac troponin level (upper limit Troponin I = 0.04 ug/L);
(5) absence of phaeochromocytoma; and (6) absence of
myocarditis or typical ischemic subendocardial/transmural
LGE on CMR. Patients with acute myocardial edema with-
out infarction not fulfilling the regional distribution criteria
for TCM all had: (a) an acute cardiac event presenting with
chest pain and/or dyspnea; (b) acute regional systolic dys-
function; (c) absence of significant (>50 %) obstructive cor-
onary artery disease; (d) new ECG abnormalities (ST
elevation or T wave inversion) and/or elevation in cardiac
troponin level (upper limit Troponin I = 0.04ug/L); (e) ab-
sence of myocarditis or typical ischemic subendocardial/
transmural LGE on CMR. Exclusion criteria included con-
traindications to CMR, known coronary artery disease,
previous myocardial infarction, myocarditis or any chronic
cardiac conditions. In addition, healthy volunteers with no
prior cardiac history or known cardiac risk factors, not on
cardiovascular medications and with a normal ECG under-
went CMR, including cine, ShMOLLI T1-mapping, STIR
and ACUT2E imaging.
Cardiovascular Magnetic Resonance
CMR studies were performed using a 1.5 T MR system
(Siemens Avanto, Germany). CMR scans assessed LV func-
tion, T1-mapping, edema and LGE, with matching short-
axis images. T1-mapping was performed using the novel
sequence ShMOLLI (Shortened Modified Look-Locker In-
version Recovery) [16]; dark-blood and bright-blood T2w-
CMR were performed with the STIR [8], and the ACUT2E
[10] sequences, respectively. All were acquired before ad-
ministration of contrast agents. A 32-channel phased-array
chest coil was used for all data acquisition, except for STIR
imaging for which the body coil was used. LGE imaging
was acquired using a T1-weighted phase-sensitive se-
quence [18] 6–10 minutes after intravenous administration
of contrast agent (Gadodiamide, Omniscan, GE Health-
care, UK, total 0.13 mmol/kg body weight at 6 ml/s).
Typical imaging parameters for SSFP cine imaging were:
voxel size 2.0x2.0x8.0 mm, TR/TE 39.6/1.12 ms, flip angle
55o, matrix 192x192; ShMOLLI T1-maps are based on 5-7
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SSFP readouts in a single breath-hold, typically: TR/TE=
201.32/1.07 ms, flip angle = 35°, matrix = 192x144, 107
phase encoding steps, interpolated voxel size = 0.9
x0.9x8mm, cardiac delay time TD=500 ms; 206 ms acqui-
sition time for single image; STIR [5]: voxel size
1.9x1.5x10.0 mm, matrix = 256x166, effective echo time
TE=61 ms, effective repetition time TR=2 RR intervals
during breath-hold, flip angle 180o, echo spacing 6.74 ms,
TI = 170 ms, dark blood thickness 200 %, dark blood flip
angle 180o, turbo factor 25, echo trains per slice = 7;
ACUT2E TSE-SSFP: voxel size 1.9x1.5x8.0 mm, matrix =
165x256, TR/TE=229.70/1.78 ms, effective TE=98 ms,
flip angle 180o, T2 prep duration=24 ms, segments = 33, 5
shots per slice, bandwidth=781 Hz/Px); phase-sensitive in-
version recovery sequence: voxel size 2.0 x 1.5 x 8.0 mm,
matrix 144x256, TR/TE=800.20/3.36 ms, flip angle 25o).
Image Analysis
Matching short axis slices were compared across cine,
ShMOLLI T1-mapping, STIR and ACUT2E imaging.
Short axis images were manually contoured using an in-
house software MC-ROI (programmed by SKP in IDL
v.6.1, www.ittvis.com) to outline the endo- and epicardium,
and then divided into 6 segments per slice using the anter-
ior right ventricular-left ventricular insertion point as refer-
ence and for comparing segments amongst sequences.
Cine images
Analysis of left ventricular ejection fraction was performed
using Argus software (Version 2002B, Siemens Medical
Solutions). Semi-quantitative assessment of wall motion
abnormality was performed in MC-ROI. Segments were
graded as: normal = 1, hypokinetic = 2, akinetic = 3, or
dyskinetic = 4.
ShMOLLI T1-maps
After T1-maps were generated, the LV myocardium was
contoured and segmented as described. The average T1
values were calculated as the average of the T1 values of all
pixels for that slice or segment using the in-house software
MC-ROI as previously described [16].
Quality assessment of T1-maps
As T1-maps are derived from non-linear estimation based
on a sequential series of SSFP images acquired after an in-
version pulse [16], factors such as off-resonance artifacts,
breathing motion and poor T1 model fit may lead to falsely
high or low T1 values. The presence of off-resonance arti-
facts and diaphragmatic movement was assessed by exam-
ination of the raw T1-weighted SSFP images. To assess for
how well T1 model fitting was achieved for each T1-map,
we used parametric maps of the goodness-of-fit (R2 maps;
see Additional file 1 for further explanation and examples).R2 maps provide an additional means to identify artifacts
and areas with potentially compromised T1 accuracy,
which allowed critical assessment of the quality of T1-
maps to increase the reliability of T1-mapping compared
to some of the standard CMR modalities. Intra- and inter-
observer variability of T1 measurements was assessed by
two operators blinded to the clinical data; one slice of T1-
map per subject was randomly pre-selected and analyzed
for all subjects in the study.Dark-blood STIR images
Quantitative analysis was performed by comparing the LV
myocardium in short axis against 2 reference regions of
interest: (1) in remote myocardium, and (2) within adjacent
skeletal muscle in the same slice, verified on a correspond-
ing SSFP image. The T2 signal intensity (SI) ratio was calcu-
lated as: (1) T2 SImyo:remote = SImyocardium/SIremote myocardium
and (2) T2 SImyo:skeletal = SImyocardium/SIskeletal muscle, as previ-
ously published [19]. Care was taken to exclude non-
suppressed blood pool signal due to slow-flow adjacent to
the subendocardium.Bright-blood ACUT2E images
Quantitative analysis was performed the same way as for
STIR images on coil intensity normalized and distortion
corrected images. If no suitable reference skeletal muscle
were available on a slice (i.e. affected by artifacts), then a
ROI with a mean SI and SD similar to that of skeletal
muscle of the nearest neighbouring slice is placed on the
index slice.Statistical analysis
Results are presented as interindividual mean±SD with
differences considered significant when p is <0.05 as
assessed by unpaired 2-tailed Student T-tests. Receiver op-
erator characteristic (ROC) analysis was performed to
identify cut-off values of T1 and T2-weighted methods for
their ability to distinguish between normal and affected
myocardial segments. Myocardial segments in patients
were considered to be affected by edema if there were
acute wall motion abnormalities (wall motion score >1) in
this clinical population as defined above, while segments in
controls with normal wall motion were considered un-
affected. As patient segments with normal wall motion
may or may not be affected by edema, these segments were
not included in the ROC analyses in order to identify opti-
mal cut-off values for the methods studied. Significance of
ROC analyses was assessed using the method of Delong
et al. [20] (MedCalc, version11.5.1.0, www.medcalc.org).
Intra- and inter-observer reproducibility of T1 mapping
measurements were assessed by using the Bland-Altman
method [21].
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Study population characteristics
Patient characteristics are presented in Table 1. Twenty-
one patients (2 males, 61 ± 10 years) and 21 age-matched
healthy controls (8 males, age 55 ± 13 years) were
included. Patients with Takotsubo cardiomyopathy had a
mean Troponin I of 8.26 ug/L (0.84-36.80 ug/L) and
patients with regional edema had a mean Troponin I of
4.28 ug/L (0.15-12.69 ug/L). Ten out of the 12 patients
with Takotsubo cardiomyopathy and six out of the 9
patients with acute regional edema had a clear stress pre-
cipitant (emotional or physical), while the rest had no
clear precipitant.
CMR Findings
The median duration between symptoms and CMR was














1 79 F ES (ACP, P) 4 51 Takotsubo
2 56 F Sz (ACP) 7 50 Takotsubo
3 70 F PS (ACP) 2 64 Takotsubo
4 60 F Nil (ACP) 2 71 Takotsubo
5 63 F PS (D) 0 59 Takotsubo
6 58 F PS (ACP, D) 1 46 Takotsubo
7 42 M Sz (ACP) 1 37 Takotsubo
8 52 F ES (ACP) 1 79 Takotsubo
9 73 F ES (ACP) 1 55 Takotsubo
10 47 F ES (ACP) 5 52 Takotsubo
11 62 F ES (ACP) 1 34 Takotsubo
12 77 F Nil (ACP) 4 66 Takotsubo
13 47 F Nil (ACP) 3 65 Regional e
14 66 F ES (ACP) 2 51 Regional e
15 65 F Nil (ACP) 1 62 Regional e
16 57 M PS (ACP, D) 0 75 Regional e
17 78 F ES (ACP) 2 58 Regional e
18 59 F ES (ACP) 4 67 Regional e
19 54 F ES (ACP) 1 66 Regional e
20 63 F Nil (ACP) 6 67 Regional e
21 55 F PS (ACP) 6 81 Regional e
*Upper limit <0.04 ug/L for TnI. ACP = acute chest pain; TnI = Troponin I; T2 SI = T2
P= palpitations; PS = Physical stress; ES = Emotionalstress; Sz = Seizure. HK = hypokin
gadolinium enhancement or coronary stenosis.Tables 1 and 2. The mean LVEF for both patients with
Takotsubo cardiomyopathy (61 ± 10 %) and regional
edema (66 ± 9 %) were significantly lower than controls
(75 ± 6 %; both p< 0.01). None had significant LGE.
Compared to controls, patients as a group had signifi-
cantly higher mean myocardial T1 values, mean myocar-
dial T2 SI myo:skeletal by dark-blood and bright-blood
T2w-CMR. There was good correlation between mean
myocardial T1 values and T2 SI ratios using dark-blood
and bright-blood T2w-CMR (r= 0.78 and 0.68, p< 0.001;
Figures 1 A and B). There was also good correlation be-
tween dark-blood and bright-blood T2w-CMR (r= 0.70,
p< 0.001; Figure 1C). There was moderate negative cor-
relation between LVEF and mean T1 values (r=−0.52,
p< 0.001), T2 SI myo:skeletal by dark-blood T2w-CMR
(r=−0.48, p< 0.002) but not with bright-blood T2w-









Mid-apical AK 3.11 1.88 2.37 1043
Mid-apical AK 15.00 1.95 1.97 1065
Mid-apical HK/AK 4.63 2.04 1.94 1051
Apical severe HK 19.98 1.89 2.20 1044
Mid ventricular AK 4.46 1.57 1.85 1001
Mid-apical AK 6.35 2.12 1.97 1032
Mid-apical HK/AK 5.00 1.93 1.64 1047
Mid inferolateral &
anteroseptal
22.75 2.29 2.56 1055
Mid-apical HK/AK 10.86 1.91 2.18 1075
Mid-apical HK/AK 0.84 2.57 2.43 1179
Mid-apical HK/AK 36.80 1.90 2.14 1111
Mid ventricular AK 5.18 1.67 2.35 1100
dema Inferolateral AK 1.30 1.57 1.98 993
dema Anterior,antero-septal AK 11.40 1.49 1.86 984
dema Mid-apical inferolateral AK 12.69 1.48 1.85 1015




0.85 1.94 2.17 1133
dema Mid-apical anterior &
anteroseptal
5.83 2.15 3.16 1113
dema Mid septum 2.63 1.56 2.07 999
dema Mid-apical anterior &
anteroseptum
3.46 2.02 2.13 1234
dema Mid anterior/
anteroseptal
0.21 1.86 2.28 1048
signal intensity (myo:skeletal); EF = ejection fraction; D= dyspnea;
esis; AK = akinesis. None of the patients demonstrated significant late
Table 2 Mean myocardial T1 and T2 SI ratios per-subject according to groups and segmental wall motion
Controls Takotsubo Regional edema All patients
ShMOLLI T1 value (ms)
Normal wall motion 944 ± 17 1026± 24 (p< 0.001) 1032 ± 86 (p< 0.02) 1029 ± 59 (p< 0.001)
Abnormal wall motion n/a 1101 ± 78 (p< 0.001) 1135 ± 120 (p< 0.001) 1113 ± 94 (p< 0.001)
Group average 944 ± 17 1064± 51 (p< 0.001) 1051 ± 98 (p< 0.01) 1059 ± 73 (p< 0.001)
STIR T2 SImyo:skeletal
Normal wall motion 1.52 ± 0.14 1.79 ± 0.25 (p< 0.01) 1.65 ± 0.22 (p = 0.14) 1.73 ± 0.24 (p< 0.001)
Abnormal wall motion n/a 2.16 ± 0.34 (p< 0.001) 1.96 ± 0.48 (p = 0.05) 2.09 ± 0.40 (p< 0.001)
Group average 1.52 ± 0.14 1.98 ± 0.26 (p< 0.001) 1.72 ± 0.28 (p = 0.08) 1.87 ± 0.29 (p< 0.001)
ACUT2E T2 SImyo:skeletal
Normal wall motion 1.77 ± 0.19 1.93 ± 0.26 (p = 0.09) 1.97 ± 0.23 (p = 0.04) 1.95 ± 0.24 (p< 0.02)
Abnormal wall motion n/a 2.34 ± 0.37 (p< 0.001) 2.49 ± 0.50 (p< 0.001) 2.40 ± 0.41 (p< 0.001)
Group average 1.77 ± 0.19 2.13 ± 0.27 (p< 0.001) 2.08 ± 0.29 (p< 0.02) 2.11 ± 0.27 (p< 0.001)
p values in brackets refer to the significance of the difference compared to values from normal controls.
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From the 42 subjects, 205 matching slices (111 patient
and 94 control slices) across cine, T1-mapping, dark-
blood T2 and bright-blood T2 sequences were available
(Figure 2). Good coverage of the LV was achieved (median
5 matching short axis slices across all sequences tested,
range 3–6 slices per case), yielding 1230 segments.
To maximize the accuracy of the threshold values to de-
tect acute myocardial edema, each segment was strictly
assessed for image quality before inclusion into the final
ROC analysis. On cine imaging, 21/1230 (1.7 %) segments
corresponding to the LVOT were rejected; on T1-maps,
142/1230 (11.5 %) segments were excluded due to off-
resonance artifacts, poor T1 fit as evidenced by the R2
maps (see Additional file 1), patient movement or low
SNR; on dark-blood STIR imaging, 94/1230 (7.6 %) seg-
ments were rejected due to insufficient image quality or
artifacts; on bright-blood ACUT2E imaging, 26/1230
(2.1 %) segments were rejected due to LVOT anatomy and
off-resonance artifacts. This yielded 1005 segments of good
quality (453 control and 552 patient segments, 230 of
which had abnormal wall motion).
ROC analysis (Figure 3) showed that for the detection of
acute myocardial edema, T1-mapping demonstrated excel-
lent diagnostic performance with a significantly larger
area-under-the-curve (AUC=0.94) compared to dark-
blood and bright-blood T2w-CMR, whether the reference
ROI was remote myocardium or skeletal muscle (p< 0.04
for all comparisons). A T1 threshold of 990 ms most opti-
mally differentiated segments affected by edema from nor-
mal segments, with a sensitivity and specificity of 92 %.
This T1 threshold reproduced the proportion of the num-
ber of abnormal to control segments used to construct this
ROC curve.
We also performed ROC analyses based on patient
groups to examine how T1-mapping performed againstthe T2 methods in detecting regional or global edema
when different reference ROIs were used.
In acute regional edema, where remote myocardium is
more appropriate as a reference ROI for the T2-weighted
methods, ROC analysis (Figure 4A) showed that both T1-
mapping and bright-blood ACUT2E had equally excellent
diagnostic performance (AUC=0.92 vs. 0.96, respectively,
p = 0.21); both were significantly better than dark-blood
STIR (AUC=0.80, p< 0.03 for both comparisons) in the
detection of regional edema.
In Takotsubo cardiomyopathy where an entire myocar-
dial slice may be diffusely edematous, skeletal muscle is a
more appropriate reference ROI for the T2 methods, and
ROC analysis (Figure 4B) showed that both T1-mapping
and dark-blood STIR had equally excellent diagnostic per-
formance (AUC=0.95 vs. 0.92, respectively, p = 0.12) over
bright-blood ACUT2E (AUC=0.83, p< 0.0001 for both
comparisons) in the detection of global edema.
Finally, to check for bias against any of the methods,
when all 1230 segments (including segments affected by
artifacts) were used, all of the original relative relationships
were preserved, with T1-mapping maintaining a signifi-
cantly larger AUC of 0.87 compared to the T2-weighted
methods (Figure 5). Relative relationships amongst meth-
ods were also preserved for ROC analyses according to pa-
tient groups (Additional file 1: Figure 6A and B).
Intra- and inter-observer agreement of T1-mapping
There was excellent correlation (r> 0.991) and agreement
between T1 estimates obtained between both blinded
operators. Bland Altman analysis of intra- and interobser-
ver variability showed that the percentage difference in T1
values was± 0.5 % (±5.6 ms) and the 95 % CI for the differ-
ences was±1.1 % of the average T1 (±11.1 ms). There were
no statistically significant differences between intra- and
interobserver variability.
Figure 1 CMR imaging modalities used for comparison – representative images in short-axis slices from: (Left panel) Normal volunteer
(Middle panel) Patient with Takotsubo cardiomyopathy. Note high T2 signal and T1 values in an apical slice. (Right panel) Patient with
regional edema in the anterior wall territory. Note high T2 signal and T1 values in the anterior, anterolateral wall and anterior septum. Rows: (A)
Dark-blood T2-weighted images (reference ROIs in skeletal muscle and remote myocardium not shown). (B) Bright-blood T2-weighted images. (C)
Colour ShMOLLI T1-maps. Green denotes normal myocardium. Red denotes increased T1 values (D) R2 maps of ShMOLLI inversion recovery fit
used to verify the quality of T1-maps. (E) LGE imaging.
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In this work, we have found that T1 is elevated in
regions with abnormal wall motion and that these
regions co-localize with regions with elevated T2. There
is strong correlation between myocardial T1 and T2 SI
ratios. Further, T1-mapping detected myocardial involve-
ment beyond that identified by wall motion abnormality.
We have demonstrated for the first time that non-
contrast T1-mapping detects acute myocardial edema
with high diagnostic accuracy compared to conventional
dark-blood and newer bright-blood T2w-CMR at 1.5 T.CMR for the detection of acute myocardial edema
Given that edema is a generic tissue response to acute
insults, edema imaging appears to be a highly suitable tool
for assessing acute myocardial injury. The “gold standard”
for defining myocardial edema on imaging, however, is
controversial [22]. Experimental animal models using
fluorescent microspheres to delineate myocardium area-at-
risk in acute MI correlated to T2w-CMR imaging [4]; how-
ever, topographic correlation between T2w images and
histopathological validation of pure myocardial edema
without infarction in humans is lacking, largely due to the
Figure 2 Relationship between: (A) myocardial T1 values and
T2 signal intensity (SI) ratio* derived from dark-blood T2w-
CMR; (B) myocardial T1 values and T2 SI ratio derived from
bright-blood T2w-CMR; (C) myocardial T2 SI ratio dark-blood
vs. bright-blood T2w-CMR. *T2 SI ratio = SImyocardium/SIskeletal muscle.
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logical samples. We thus decided to study patients present-
ing with cardiac conditions known to involve acute edema
but without co-existing infarction or other pathology
detected by LGE. In Takotsubo cardiomyopathy and acute
myocardial stunning, inflammation and edema are main
features described on human endomyocardial biopsies and
animal models [23-25]. Although patients with regional
edema did not fulfill criteria for the typical patterns of
Takotsubo cardiomyopathy, and possible mechanisms may
include coronary spasm or plaque events, the cases preci-
pitated by an emotionally stressful event may represent an
atypical form of stress-induced cardiomyopathy not fitting
the traditional description of apical ballooning or other
morphologic variants commonly described [17]. There was
no viral history to suggest a myocarditic process. The com-
mon feature for all patients in this study was that all had
acute wall motion abnormalities associated with edema
without infarction on CMR. While not proven histologi-
cally in our cohort, it is highly likely that segments with
acute wall motion abnormality would demonstrate features
of acute edema. Our assumption was strongly supported
by the fact that segments with abnormal wall motion
showed numerically higher average T2 SI ratio and T1
values than controls.
ShMOLLI T1-mapping: a novel method for imaging
myocardial edema
We recently developed the ShMOLLI technique for fast
T1-mapping [16], which overcomes many of the limita-
tions of both conventional MOLLI T1-mapping and dark-
blood T2w-CMR. Compared to MOLLI, ShMOLLI is
~50 % shorter in breath-hold times; it is also heart rate-
and T1-independent over a wide range of T1 values, and
thus is more accurate in measuring long T1s in edema and
at fast heart rates [16]. Compared to dark-blood T2w-
CMR , ShMOLLI is robust to tachycardia (shown in simu-
lation and phantoms for rates up to 100 bpm [16] and
tested in clinical subjects with sinus tachycardia and atrial
fibrillation at ventricular rates of up to 150 bpm; unpub-
lished own data). It does not suffer from signal dropout
due to through-plane cardiac motion and breath-holds are
considerably shorter.
Bright-blood T2 is excellent for detecting large areas of
regional edema when there is obvious normal myocardium
to be used as a reference, as shown recently [3] and in this
work. The main challenge of extending bright-blood T2
Figure 3 Receiver operator characteristic curves for the detection of acute myocardial edema by ShMOLLI T1-mapping, dark-blood
T2w-CMR and bright-blood T2w-CMR. For T2-weighted methods, reference regions of interest for comparison of myocardial signal intensity
are specified in brackets. AUC= area-under-the-curve.
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ity of the image quality of reference skeletal muscle, which
was often affected by off-resonance artifacts, bright signals
from adjacent fat, bright blood vessels within the muscle or
signal dropouts. For this reason, STIR outperformed
bright-blood ACUT2E in this setting as STIR images have
a more homogenous signal across the field of view, and
thus the quality of the skeletal muscle was generally better,
more consistent and more reliable. This study suggests that
bright-blood T2 may not always be suitable as a replace-
ment method for conventional dark-blood T2w-CMR.
T1-mapping using ShMOLLI has now been shown to be
highly sensitive to acute changes in myocardial water char-
acteristics which, up to this point, have been evaluated
mainly using T2w-CMR. From a mechanistic point of view,
T1-mapping and T2-weighted MRI likely detect acute
myocardial injury via distinct, but complementary and
overlapping mechanisms. Interestingly, we detected signifi-
cant T1 elevation even in patient segments with normal
wall motion (Table 1), a finding accompanied also by sig-
nificantly higher T2 SI in segments with normal wall mo-
tion in Takotsubo patients (by dark-blood STIR but not
bright-blood ACUT2E) as well as in patients with regional
edema (by bright-blood ACUT2E but not dark-bloodSTIR). This suggests that T1-mapping may be the more
sensitive technique in detecting acute myocardial changes
in both global and regional pathologies, and/or detects
myocardial changes beyond that identified by wall motion
abnormality and the T2-weighted methods tested. Previous
experimental work demonstrated that T1 relaxation times
are prolonged in regionally ischemic tissue from dog
hearts, and while largely reflective of increased free water
content of the ischemic tissue, T1 changes exceeded the
changes in water content as the duration of ischemia was
increased [13]. The prolongation of T1 values was found to
be unrelated to changes in metabolic parameters such as
tissue content of oxygen, carbon dioxide, hydrogen ions,
lactate, adenosine triphosphate or phosphocreatine [13].
Rather, it was postulated that T1 changes may be related to
changes in both total water content as well as the relative
amounts of water in intracellular and extracellular com-
partments. Furthermore, changes in sodium and potassium
contents and their distribution may impact on the mo-
tional freedom of water protons, contributing to prolonga-
tion of T1 values in ischemic tissue [13]. Indeed, both of
these processes are part of edema evolution in ischemic in-
jury to the myocardium [1]. Thus, while increased T1
values in acutely injured myocardium may largely reflect
Figure 4 Receiver operator characteristic curves for the detection of acute myocardial edema according to patient groups using
ShMOLLI T1-mapping, dark-blood T2w-CMR and bright-blood T2w-CMR. (A) Patients with regional edema vs. controls. (B) Patients with
Takotsubo cardiomyopathy vs. controls. AUC= area-under-the-curve.
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Figure 5 ROC curves for the detection of acute myocardial edema by ShMOLLI T1-mapping, dark-blood T2w-CMR and bright-blood
T2w-CMR using only segments of good quality for all methods (left panel), and using all available segments, including segments
previously rejected for artifacts for all methods (right panel). This shows that ShMOLLI T1-mapping retains its superiority despite the
re-inclusion of segments affected by artifacts. All comparisons are statistically significant (p< 0.03). AUC= area-under-the-curve.
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are more readily detected by T1-mapping and to which
T2w methods are less sensitive. The precise nature of what
these changes are that prolong T1 values will need to be
further investigated, but ShMOLLI T1-mapping is a dis-
tinct yet complementary technique to T2w-CMR, which
adds to our current repertoire of available sequences for
assessing acute myocardial injury.
T1-mapping holds potential to quantify both extent and
severity of disease and may provide further insights into
conditions where T2w-CMR has proven useful. These in-
clude quantifying myocardial salvage in acute MI, deter-
mining the age of myocardial injury, diagnosing acute
myocarditis and cardiac transplant rejection. It may also be
useful in describing subacute conditions where myocardial
inflammation is implicated, such as cardiac sarcoidosis
[26], amyloidosis, and hypertrophic cardiomyopathy [6].
T1-mapping has also been shown to detect changes in
chronic cardiac conditions involving diffuse fibrosis [27-
29], which is characterized by increased collagen and aque-
ous content within the myocardium, leading to interstitial
expansion.
Unlike the T2w methods examined, ShMOLLI T1-
mapping does not require a-priori knowledge of where
affected and unaffected myocardium (if any) should be for
image analysis; it reports absolute T1 values, obviating the
need for a reference ROI, and thus has an excellent per-
formance in different models of edema, whether regionalor global. Accordingly, T1-mapping can be useful in path-
ologies where edema maybe diffuse, patchy or not immedi-
ately obvious to the eye. Immediate visualization of the
extent of injury may be facilitated by dedicated color
schemes based on quantitative thresholds, an example of
which is shown in Figure 2.
Quality and reliability of T1-maps
As our T1-mapping method is novel, we aimed to be as ac-
curate as possible in setting the most optimal cut-off value
for detecting edema and thus were stringent on selecting
only the best segments (without any or with only minimal
artifacts) to include in the analysis. This was one of the rea-
sons for the apparently higher rejection rate for T1-
mapping compared to other modalities. T1-maps were
assessed for quality and reliability in three ways: visual in-
spection of the T1-map itself, visual inspection of all seven
of the raw T1 images for potential artifacts, and the use of
R2 maps to ensure that the T1 fit is robust for all segments
on the T1-map. The feature of R2 maps is described in de-
tail with examples in the Additional file 1, and serve as a
more objective way to detect segments with poor T1 fit
that may not be obvious to the eye; T2-weighted methods
tested in this study, on the other hand, do not have this
added feature for quality assurance and so their rejection
rate may be underestimated. We consider the fact that
ShMOLLI T1-mapping has multiple ways for detecting
regions with potentially compromised T1 values a strength
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observer bias. ACUT2E is also a relatively novel method
that has been validated in acute MIs [3], but not in detect-
ing global edema or non-ischemic pathologies; sometimes,
it is unclear whether darker areas within the myocardium
are due to SSFP artifacts (as in Figure 2B, middle panel) or
whether it is representative of normal myocardium (as in
Figure 2B (right panel) versus signal drop-out/artifact in
the inferolateral wall (less likely in this case). These reasons
contribute to the apparently higher rejection rate of T1-
mapping, but do not reflect that the method is artifact-
prone; rather, we were strict on selecting only the best seg-
ments for the purpose of establishing T1 thresholds with
the greatest accuracy.
As presented in the Results section, to check for bias
against any of the methods tested, when we re-included all
rejected segments affected by artifacts, it was reassuring to
note that all of the original relative relationships on the
ROC analysis were preserved, with T1-mapping maintain-
ing its superior diagnostic performance with a significantly
larger AUC of 0.87 compared to the T2-weighted methods
(Figure 5). Relative relationships amongst methods were
also preserved for ROC analyses according to patient
groups (Additional file 1: Figure 6A and B).Limitations
ShMOLLI T1-mapping sometimes demonstrated typical
SSFP susceptibilities to off-resonance artifacts and partial
volumes effects, especially in very apical slices. These may
be circumvented with frequency shifting and potentially by
wide-band SSFP. As artifacts may cause falsely high or low
T1 values, it is important to have methods for assessing
the quality and robustness of T1-maps, such as those used
in this study (see Additional file 1). ShMOLLI underesti-
mates the true T1 value by 4 % but in a consistent manner
[16]. Thus, when comparing T1 values measured by differ-
ent T1-mapping techniques, corrected T1 values and
thresholds should be used.
As discussed, it is challenging to establish an in-vivo and
histopathological reference gold standard for acute myo-
cardial edema; thus, this study used acute regional wall
motion abnormality without evidence of infarction as the
best clinical surrogate for edema in a carefully selected
study population. Pre-contrast increase in myocardial T1
value is non-specific and may be seen in a number of con-
ditions, including acute myocardial injury, chronic infarct
scar [14] and cardiac amyloidosis [30], and thus must be
interpreted within the clinical context. Moreover, changes
of T1 and T2 within the myocardium are dependent on
different mechanisms, but the two are closely related. The
precise mechanisms leading to increased T1 relaxation
times in acutely injured myocardium remain to be
established.Thirdly, T2-mapping is another technique which may be
used to detect edema [31] but was not studied in this work.
We did, however, compare T1-mapping to the state-of-the
-art bright-blood ACUT2E sequence [10], which has re-
cently been shown to be superior to conventional dark-
blood STIR imaging in acute MI [3]. Future work will have
to directly compare T1 and T2 mapping techniques.
Conclusion
ShMOLLI T1-mapping is a novel, quantitative method that
we have clinically validated for detecting acute myocardial
edema. It has a high diagnostic performance compared to
dark-blood and bright-blood T2w-CMR, due to both tech-
nical advantages and mechanistic differences. T1-mapping
using ShMOLLI holds potential to quantify both extent
and severity of disease and may provide further insights
into conditions where T2w-CMR has proven useful. We
predict wide clinical applicability of this promising tech-
nique to study a variety of cardiac conditions in future
studies.
Additional file
Additional file 1: Supplemental Material. Image Post-processing.
Quality assessment of T1-maps – the use of R2 maps. Figure 6. Receiver
operator characteristic curves according to patient groups for the
detection of acute myocardial edema using all segments, including
segments previously rejected for artifacts for all methods. (A) Patients
with regional edema vs. controls. (B) Patients with Takotsubo
cardiomyopathy vs. controls. AUC=area under the curve.
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